Cargando…

Epigenetics and MicroRNAs in Cancer

The ability to reprogram the transcriptional circuitry by remodeling the three-dimensional structure of the genome is exploited by cancer cells to promote tumorigenesis. This reprogramming occurs because of hereditable chromatin chemical modifications and the consequent formation of RNA-protein-DNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramassone, Alice, Pagotto, Sara, Veronese, Angelo, Visone, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855681/
https://www.ncbi.nlm.nih.gov/pubmed/29401683
http://dx.doi.org/10.3390/ijms19020459
_version_ 1783307153735417856
author Ramassone, Alice
Pagotto, Sara
Veronese, Angelo
Visone, Rosa
author_facet Ramassone, Alice
Pagotto, Sara
Veronese, Angelo
Visone, Rosa
author_sort Ramassone, Alice
collection PubMed
description The ability to reprogram the transcriptional circuitry by remodeling the three-dimensional structure of the genome is exploited by cancer cells to promote tumorigenesis. This reprogramming occurs because of hereditable chromatin chemical modifications and the consequent formation of RNA-protein-DNA complexes that represent the principal actors of the epigenetic phenomena. In this regard, the deregulation of a transcribed non-coding RNA may be both cause and consequence of a cancer-related epigenetic alteration. This review summarizes recent findings that implicate microRNAs in the aberrant epigenetic regulation of cancer cells.
format Online
Article
Text
id pubmed-5855681
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-58556812018-03-20 Epigenetics and MicroRNAs in Cancer Ramassone, Alice Pagotto, Sara Veronese, Angelo Visone, Rosa Int J Mol Sci Review The ability to reprogram the transcriptional circuitry by remodeling the three-dimensional structure of the genome is exploited by cancer cells to promote tumorigenesis. This reprogramming occurs because of hereditable chromatin chemical modifications and the consequent formation of RNA-protein-DNA complexes that represent the principal actors of the epigenetic phenomena. In this regard, the deregulation of a transcribed non-coding RNA may be both cause and consequence of a cancer-related epigenetic alteration. This review summarizes recent findings that implicate microRNAs in the aberrant epigenetic regulation of cancer cells. MDPI 2018-02-03 /pmc/articles/PMC5855681/ /pubmed/29401683 http://dx.doi.org/10.3390/ijms19020459 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ramassone, Alice
Pagotto, Sara
Veronese, Angelo
Visone, Rosa
Epigenetics and MicroRNAs in Cancer
title Epigenetics and MicroRNAs in Cancer
title_full Epigenetics and MicroRNAs in Cancer
title_fullStr Epigenetics and MicroRNAs in Cancer
title_full_unstemmed Epigenetics and MicroRNAs in Cancer
title_short Epigenetics and MicroRNAs in Cancer
title_sort epigenetics and micrornas in cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855681/
https://www.ncbi.nlm.nih.gov/pubmed/29401683
http://dx.doi.org/10.3390/ijms19020459
work_keys_str_mv AT ramassonealice epigeneticsandmicrornasincancer
AT pagottosara epigeneticsandmicrornasincancer
AT veroneseangelo epigeneticsandmicrornasincancer
AT visonerosa epigeneticsandmicrornasincancer